Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
Vaccines containing acellular pertussis components, either separate or combined with other microbial antigens, were evaluated for specific immune responses in guinea-pigs and mice. The capacity of sera to protect chick embryos from the lethal effect of pertussis toxin was independent of the Chinese hamster ovary cell clumping neutralization titre and the antigen binding ELISA anti-toxin titre. Direct correlations did not exist between ELISA titres to Pt, FHA, fimbria or 69 kDa and capacity to prevent killing of embryos by different strains of Bordetella pertussis. With the exception of one combination vaccine product, addition of foreign microbial antigens to acellular pertussis vaccines did not significantly alter capacity of the sera to protect embryos against toxin or bacteria.
Calver
G A
GA
Vaccine Division, Bureau of Biologics & Radiopharmaceuticals, Therapeutic Products Programme Health Canada, Ottawa, Ontario, K1A 0L2, Canada.
D000818:Animals; D001886:Bordetella pertussis / Q000276:immunology*; D002642:Chick Embryo; D006224:Cricetinae; D004797:Enzyme-Linked Immunosorbent Assay; D006168:Guinea Pigs; D007106:Immune Sera; D051379:Mice; D009500:Neutralization Tests; D037342:Pertussis Toxin; D010567:Pertussis Vaccine / Q000276:immunology*; D010566:Virulence Factors, Bordetella / Q000276:immunology*
D007106:Immune Sera; D010567:Pertussis Vaccine; D010566:Virulence Factors, Bordetella; D037342:Pertussis Toxin